Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-6607.31%EBITDA Margin
VS
Market
Sector
Industry
History
$ 0.23Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information
Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCNORTHWEST BIOTHERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NWBO - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -72.28M | -6607.31% | $ 1.09M |
| 3/31/2025 | $ -74.92M | -5086.29% | $ 1.47M |
| 12/31/2024 | $ -73.97M | -5352.17% | $ 1.38M |
| 9/30/2024 | $ -65.99M | -4134.65% | $ 1.6M |
| 6/30/2024 | $ -65.64M | -3990.15% | $ 1.65M |
| 3/31/2024 | $ -62.69M | -4692.44% | $ 1.34M |
| 12/31/2023 | $ -55.63M | -2879.14% | $ 1.93M |
| 9/30/2023 | $ -65.06M | -3122.07% | $ 2.08M |
| 6/30/2023 | $ -79.61M | -4225.58% | $ 1.88M |
| 3/31/2023 | $ -94.54M | -4376.67% | $ 2.16M |
Key Performance Insights, Last 5 Years
- NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -13957.69%.
- Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average EBITDA % has been -7879.88%.
- The median EBITDA % for NORTHWEST BIOTHERAPEUTICS INC during this period was -4534.55%
- NORTHWEST BIOTHERAPEUTICS INC reached its highest EBITDA % over the past 5 years at 18380.4%.
- The lowest EBITDA % recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe -54855.42%
NORTHWEST BIOTHERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: EBITDA [ $ -235.19M ] / Revenues [ $ 1.69M ]
(=) EBITDA % [ -13957.69% ] NWBO - EBITDA Margin, Last 5 years
-54855.42%
Minimum
Mar 31, 2021
18380.4%
Maximum
Dec 31, 2021
-7879.88%
Average
-4534.55%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.89%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.89% |